DANA Compared to MACE in Evaluation of Suspected Acute Concussion

计划入组 40 人 · 首次发布于 2012 年 11 月 16 日

Contextualizing & Responding to HIV Risk Behaviors

计划入组 32 人 · 首次发布于 2017 年 10 月 4 日

AI-Based Risk Factor Analysis and Prediction Model of MACE in Elderly Hip Fracture Patients Postoperatively

计划入组 600 人 · 首次发布于 2026 年 7 月 16 日

Myristica fragrans fruit

CAR-NK cell therapy (City of Hope)

Macelignan

C₂₀H₂₄O₄

Macerich Co

A.C.O.M. - Advanced Center Oncology Macerata - Srl

Italy

秦皇岛山海关药业股份有限公司

MACE Endpoint Faces Scrutiny in Cardiovascular Trials

Novo Nordisk's Ziltivekimab Fails Phase 3 ZEUS Trial, Missing Primary MACE Endpoint in Cardiovascular Disease

GLP-1 Receptor Agonists Show Lower Risk for MACE and VTE in Lupus and Type 2 Diabetes Patients Compared to DPP4 Inhibitors